Scarborough Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Scarborough Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,179	Closed	-$31.2K	–	186
2026 Q1	$31.2K	Hold	1,179	–	–	﹤0.01%	287
2025 Q4	$34.2K	Buy	1,179 +225	+24%	+$6.75K	0.01%	161
2025 Q3	$26.5K	Hold	954	–	–	﹤0.01%	170
2025 Q2	$23.2K	Buy	+954	New	+$20.9K	﹤0.01%	183
2024 Q3	–	Sell	-1,081	Closed	-$25.4K	–	133
2024 Q2	$25.4K	Hold	1,081	–	–	0.01%	146
2024 Q1	$31.1K	Buy	1,081 +400	+59%	+$12K	0.01%	131
2023 Q4	$22.3K	Buy	+681	New	+$18.5K	﹤0.01%	268

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Scarborough Advisors's ARKG Position: Q2 2026 in Review

Scarborough Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 1,179 shares — an estimated $31.2K sold.

Scarborough Advisors first reported a position in ARKG in Q4 2023 and held it in 7 quarters. The position peaked at $34.2K in Q4 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Scarborough Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Scarborough Advisors sold 1,179 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $31.2K.
Scarborough Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 7 quarters.
Scarborough Advisors's ARK Genomic Revolution ETF position peaked at $34.2K in Q4 2025.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.